GRAFT VERSUS HOST DISEASE, ACUTE
Clinical trials for GRAFT VERSUS HOST DISEASE, ACUTE explained in plain language.
Never miss a new study
Get alerted when new GRAFT VERSUS HOST DISEASE, ACUTE trials appear
Sign up with your email to follow new studies for GRAFT VERSUS HOST DISEASE, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy aims to tame deadly transplant complication
Disease control Recruiting nowThis study tests a new treatment called CYP-001 for people with a severe complication after a bone marrow or stem cell transplant, known as graft versus host disease (GvHD). The trial will compare CYP-001 plus standard steroids to steroids alone in 60 participants. The goal is to…
Matched conditions: GRAFT VERSUS HOST DISEASE, ACUTE
Phase: PHASE2 • Sponsor: Cynata Therapeutics Limited • Aim: Disease control
Last updated May 26, 2026 05:10 UTC
-
Poop pills may prevent deadly transplant complication
Prevention Recruiting nowThis study tests whether giving patients their own healthy gut bacteria (via a fecal transplant) can prevent acute graft-versus-host disease (GVHD) after a half-matched stem cell transplant. About 100 bone marrow transplant patients will be randomly assigned to receive the fecal …
Matched conditions: GRAFT VERSUS HOST DISEASE, ACUTE
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated May 22, 2026 14:03 UTC